SIEGALL CLAY B
SEC CIK 1167496 · EDGAR
BoughtSold
Most active insiders at IMNM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barchas Isaac | Dir | — | $18.27M |
| 2 | Rosett Max | CFO | — | $2.52M |
| 3 | Lechleider Robert | Chief Medical Off | — | $2.34M |
| 4 | Horn Kinney | Chief BUSINESS Off | — | $2.30M |
| 5 | SIEGALL CLAY B | Pres, CEO, Dir | $1.75M | — |
| 6 | WAGENHEIM PHILIP | Dir | — | $1.34M |
| 7 | BIENAIME JEAN JACQUES | Dir | $351.4K | $203.8K |
| 8 | Higgins Jack | CSO | — | $538.5K |
| 9 | Tsai Philip | Chief Technical Off | $204.9K | — |
| 10 | Stoneman Sandra G. | CLO, GC | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | A - Grant | $0.00 | +180.0K | 870.7K | +26% | $0 |
| 2026-06-11 17:00 | 2026-06-09 | STTK | Shattuck Labs, Inc. | SIEGALL CLAY B | Dir | P - Purchase | $4.00 | +62.5K | 318.6K | +24% | +$250.0K | |
| D | 2026-05-27 06:05 | 2026-05-22 | STTK | Shattuck Labs, Inc. | SIEGALL CLAY B | Dir | A - Grant | $1.08 | +128.1K | 256.1K | +100% | +$138.9K |
| 2026-03-31 | 2026-03-27 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $19.67 | +25.4K | 690.7K | +4% | +$500.6K | |
| 2025-12-30 | 2025-12-30 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $21.15 | +4,729 | 665.3K | +0.7% | +$100.0K | |
| 2025-12-22 | 2025-12-19 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | G - Gift | $0.00 | -200.0K | 660.5K | -23% | $0 | |
| 2025-12-22 | 2025-12-19 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $20.48 | +7,278 | 860.5K | +0.9% | +$149.1K | |
| 2025-12-18 | 2025-12-18 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $21.50 | +46.5K | 853.2K | +6% | +$1000.0K | |
| D | 2025-08-27 | 2025-08-25 | STTK | Shattuck Labs, Inc. | SIEGALL CLAY B | Dir | A - Grant | $0.87 | +128.1K | 128.1K | New | +$111.4K |
| 2025-03-26 | 2025-03-26 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $7.29 | +137.1K | 806.7K | +20% | +$999.5K | |
| 2025-02-03 | 2025-01-31 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $7.75 | +150.0K | 669.6K | +29% | +$1.16M | |
| M | 2024-11-25 | 2024-11-21+ | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $9.62 | +100.0K | 519.6K | +24% | +$962.1K |
| M | 2024-05-21 | 2024-05-20+ | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $13.88 | +100.0K | 419.6K | +31% | +$1.39M |
| 2023-10-04 | 2023-10-02 | IMNM | Immunome Inc. | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $5.91 | +169.2K | 319.6K | +112% | +$1000.0K |
Purchase Sale Sale after option exercise All abbreviations